Skip to main content
Equibles
ADIA logo

ADIA · Adia Nutrition, Inc. · Metrics

Track ADIA — free

Use ADIA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADIA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.11 -0.03 (-22.79%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern for one year after the audit report is dependent upon, among other things, its ability to generate greater revenues and its ability to obtain capital from third parties. No assurance can be given that the Company will be successful in these efforts.”
View the 10-Q filed Aug 13, 2026
Market Cap
$14.16M
Shares
94.40M
Volume · Oct 2 139.35K Avg daily vol (3M) 15.83K

ADIA metrics

54 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.11
Market cap
$14.16M

Price action

20 metrics
Price change (1W)
-27.9%
Price change (30D)
-19.9%
Price change (3M)
-29.8%
Price change (6M)
-9.2%
Price change (YTD)
+38.6%
Price change (1Y)
+145.7%
Trailing year
Price change (5Y)
+5,305.0%
52-week high
$0.24
52-week low
$0.03
Change from 52-week high
-55.7%
Change from 52-week low
+332.4%
Annualized volatility
267.6%
Annualized volatility (3M)
—
Beta
3.6
RSI (14D)
41.5
Price vs SMA 50
-16.4%
Price vs SMA 200
-18.1%
Avg volume (3M)
15,827
Relative volume
8.8
Average dollar volume
$2,043

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
94.40M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
12.1×
reciprocal yield 8.3%
P / book
—
FCF yield
-1.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
42.8%
Operating margin
-20.4%
Trailing 12 months
Net margin
-23.7%
Gross profit (TTM)
$501,852
Operating profit (TTM)
−$239,453
Net income (TTM)
−$277,355
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-15.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+310.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.17M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+80.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-37.3%
Debt / equity
—
Current ratio
0.3
EBITDA (TTM)
−$234,532
Free cash flow (TTM)
−$181,261
Quick ratio
—
Interest coverage
-5.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$128,115
Latest balance sheet
Cash & equivalents
$128,115
Total assets
$744,054
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$175,765
Capital expenditures (TTM)
$5,496
R&D (TTM)
$4,528
SG&A (TTM)
—
Stock compensation (TTM)
$42,250
R&D / revenue
0.4%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1160420 CUSIP 00687W109 Visit website Investor relations